Announces encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with apalutamide in patients with mCRPC. Entered into clinical tr ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback